At UCB, our purpose is to create value for patients and their families both now and in the future, elevating their lives through our medicines – and beyond.

A Bigger Picture: When it comes to our commitment to people living with rare diseases like myasthenia gravis (MG), we know that driving meaningful outcomes requires innovation – not only in the treatments we deliver, but the wider contributions we make to help elevate patients’ lives. Together, our therapies, research, and advocacy form a continuous support system for this community.

Innovative Treatments: No two people living with generalized myasthenia gravis (gMG) are alike, and everyone responds to treatment differently, which is why our team is proud to offer two targeted therapies for adults with gMG. gMG is a more severe type of MG that can weaken muscles throughout the body.

Research Beyond Treatment: Our medical contributions are only one piece of the puzzle when it comes to our research. Each day, we seek to discover a deeper, more comprehensive understanding of the MG community – where they live, what they do, and how they interact with the environments that surround them – each detail playing an important role in their MG journey and overall wellbeing and informing our work.

• By actively listening to and learning from patients and caregivers, and partnering with key players across the community, our research has identified gaps in care and how we can work towards meaningful improvements, helping families spend less time focused on managing the disease, and more on simply living.
• At AANEM 2025, UCB presented Subpopulations with Barriers to gMG Care Panel Discussion, a panel discussion moderated and led by HCP experts, UCB Medical, and patient advocates. The panel discussed topics important to the MG community, such as underserved and under-resourced populations in MG, including women with MG, and dove into special populations that are underserved due to socio-economic factors, rural location, language, and others and that affect communities disparately. This panel also considered MG clinic outcomes and barriers to effective care for subpopulations in gMG.

Community Commitments: Beyond our research, UCB is dedicated to creating value for the MG community, reaching people where they are to provide the support they need. Over the years, we have worked with advocates, community leaders, and like-minded innovators to launch innovative new programs that enhance community collaboration, such as:

• The UCB Myasthenia Gravis Scholarship™ program, which helps people living with MG or their immediate family members pursue further education. Whether continuing education or exploring a new career, our scholarships can help cover educational expenses.
• Our advocacy partnerships across the MG community aim to understand and tackle issues such as delayed diagnosis, lack of recognition, and barriers to accessing support and care. By working with groups like the Myasthenia Gravis Foundation of America (MGFA), we can provide education, information, and valuable tools to the community.
• We believe in creating resources for the MG community to meet them where they are, whether with our Simple Spoonfuls nutritional series or working with our partners at the Emerson Diversity Health Foundation to sponsor four special episodes of Tu Salud Tu Familia, a widely watched Spanish-language medical television show, centered on educating about MG and empowering the community.

Continuing the Journey: We believe that every person living with MG deserves the opportunity to be healthy, and our research and initiatives aim to not only improve health outcomes but enable better quality of life for those we serve. Looking ahead, we will continue to listen, we will continue to learn, and we will continue to focus just as much on delivering scientific and regulatory milestones as we do on reaching patients where they are to elevate lives beyond medicine.

The content of this article is intended for a U.S. audience only.
UCB Myasthenia Gravis Scholarship™ is a trademark of the UCB Group of Companies.
©2025 UCB, Inc., Smyrna, GA 30080. All rights reserved. US-DA-2500777